肺癌治疗中的免疫疗法的自身免疫副作用从大型队列研究中揭示出来
1H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, 755 Ferst Dr NW, Atlanta, 30318, Georgia, USA.
medRxiv : the preprint server for health sciences
|December 16, 2024
概括
免疫检查点抑制剂虽然对肺癌有效,但与化疗相比,免疫相关不良反应 (irAEs) 的风险更高. 这项大规模研究量化了这些风险,强调了需要仔细监测免疫治疗副作用的必要性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药物监督 药物监督 药物监督
背景情况:
- 免疫检查点抑制剂 (ICI) 在肺癌治疗中提供了显著的生存益处.
- 然而,ICI与免疫相关的不良影响 (irAEs) 有关,其大规模量化仍然具有挑战性.
- 现有关于irAE机制的研究需要现实世界的数据来进行人口层面的风险评估.
研究的目的:
- 在一大群患者中,比较多次ICI与化疗的自身免疫相关风险.
- 为了确定特定的ICI治疗和与高IRAE风险相关的自身免疫疾病.
- 为了验证一个方法来评估新疗法的副作用在规模上.
主要方法:
- 利用了超过10万名患者 (2012-2018) 的医疗补助和CHIP TAF数据.
- 在接受ICI和化疗的患者之间比较irAE发生率.
- 进行了亚种群分析,特定疾病类型分析和敏感性分析.
主要成果:
- 与化疗相比,ICI在未调整和调整的分析中显示,IREs的发病率显著更高.
- 特定的ICI治疗与增加的irAE风险有关,观察到某些自身免疫性疾病风险的变化.
- 敏感性分析证实了这些发现的可靠性.
结论:
- ICI与化学疗法相比,IREs的风险要大得多.
- 对自身免疫性副作用的持续监测对于ICI治疗至关重要.
- 使用的方法可以评估新疗法的有效性和安全性在现实世界的人群中.
更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
16.8K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K